Jamp Bisoprolol 5 mg tablet: may contain a foreign tablet
Brand(s)
Last updated
Summary
Product
Jamp Bisoprolol 5 mg tablet
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot number |
|---|---|---|---|---|---|
| Jamp Pharma | Jamp Bisoprolol 5 mg tablet | DIN 02518805 | Tablet | Bisoprolol fumarate 5 mg | MTE0122A |
Issue
The affected batch may contain a foreign Rosuvastatin 20mg tablet.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
JAMP PHARMA CORPORATION
1310 rue Nobel,
Boucherville, QC, J4B 5H3 Canada
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-77896
Get notified
Receive notifications for new and updated recalls and alerts by category.